Insurers’ Opportunities in M&A: 5 Questions Insurers Should Ask Before Committing Capital

Insurers’ Opportunities in M&A: 5 Questions Insurers Should Ask Before Committing Capital
November 5, 2026 9 mins

Insurers’ Opportunities in M&A: 5 Questions Insurers Should Ask Before Committing Capital

Insurers’ Opportunities in M&A: 5 Questions Insurers Should Ask Before Committing Capital

Insurers have more ways to grow than ever, but not every challenge calls for an acquisition. Aon’s Ownership Decision Framework helps evaluate acquisition, partnership, investment and internal build options against growth objectives.

Key Takeaways
  1. M&A should begin with the problem, not the asset. Insurers need to define the strategic constraint before deciding whether ownership is the right answer.
  2. Deployable capital is the real test. The question is not how much capital is available, but how much can be deployed without weakening resilience, ratings, earnings quality or strategic flexibility.
  3. Preserving optionality can be an important governance consideration. Partnerships, minority investments and staged ownership can help insurers act with discipline while preserving future choices.

Insurers rarely lack growth options. The harder question is which option deserves capital, management attention and board support. An acquisition may offer speed and scale, but it may also bring integration risk, earnings volatility and capital strain. A partnership may preserve flexibility, but it may not deliver enough control. Building internally may protect culture, but it can take longer than the market allows. Many insurers are evaluating value creation through both the strategic pathway they pursue and the flexibility they retain as market conditions evolve.

That is why M&A should be tested as one pathway within a broader growth strategy, not treated as the strategy itself. Aon’s Growth Decision Framework helps leaders evaluate potential growth pathways through a structured decision-making process. The Ownership Decision Framework applies those principles specifically to ownership, capital deployment and execution choices.

Quote icon

Boards are no longer asking whether they can execute a deal. They are asking whether ownership is the best use of capital relative to every other pathway available to them. That requires a disciplined decision framework.

Kathleen Monaghan Ballo
Head of Corporate Finance

The Ownership Decision Framework

1. Define the Strategic Constraint

The first question is not “Is there a deal?” It is “What constraint are we trying to solve?”

For one insurer, the constraint may be limited access to specialty underwriting talent. For another, it may be geographic concentration, underdeveloped distribution, technology capability or pressure on long-term earnings relevance.

Talent gaps may be addressed through hiring, partnership or acquisition. Technology gaps may require investment, alliance or build. Geographic concentration may call for acquisition, reinsurance support or a staged market entry.

Defining the constraint clearly reduces the risk of using M&A as a shortcut for a problem that another pathway could solve with less capital, less complexity or greater flexibility.

2. Test Pathways Before Ownership

Before pursuing control, insurers should test whether the same objective can be achieved through internal investment, operating model redesign, partnership, structured capital, minority ownership or a staged move.

This is where the Ownership Decision Framework shifts the discussion from growth ambition to ownership decisions. The key question is whether control is necessary, whether it is worth the cost and whether a different structure could deliver the strategic outcome with less execution risk.

A full acquisition may be right when speed, control and integration are important strategic objectives. A partnership may be appropriate when the insurer seeks access, learning or market entry without immediate balance sheet strain. A minority investment may work when alignment matters but full ownership is premature.

The comparison, however, should be between realistic alternatives rather than idealized ones. Acquisitions rarely deliver every capability a buyer wants. Internal build can take longer, cost more or prove harder to execute than expected. Partnerships may introduce governance complexity, slower decision-making or less control than initially anticipated. Effective pathway assessment requires leaders to compare the likely real-world outcomes of each option against the specific constraints, capabilities and market conditions facing their organization.

3. Separate Available Capital From Deployable Capital

Available capital does not always equal deployable capital. A board may have balance sheet capacity to fund a transaction and still decide not to deploy it if the deal would weaken ratings, earnings resilience, regulatory confidence or investor trust.

Deployable capital should be assessed not only against funding capacity, but also against capital consumption, rating agency expectations and long-term risk-adjusted returns. The question is not whether a deal can be financed. It is whether capital can be committed without reducing strategic flexibility.

In practice, this means testing more than headline balance sheet capacity. Boards should assess how a transaction affects solvency headroom, rating agency expectations, earnings resilience and future capital flexibility under a range of operating scenarios. Deployable capital is not simply available capital. It is capital that can be committed without undermining the organization’s ability to absorb shocks, invest elsewhere or respond to changing market conditions.

Reinsurance, structured capital and staged ownership may support deployment, but they do not remove the need for discipline. In some cases, the better decision is not to avoid growth, but to choose a pathway that protects capital flexibility while still advancing the strategic objective.

4. Assess Execution Capacity

A pathway that looks attractive in a board paper can fail if the organization cannot execute it. Before committing to M&A, insurers should assess whether they have the leadership capacity, integration discipline, technology compatibility, talent plan and cultural alignment required to achieve the transaction’s intended strategic objectives.

This assessment should be honest. If the business is already managing transformation, regulatory change or underwriting-cycle pressure, a complex acquisition may add more strain than value. If the target’s most important asset is talent rather than infrastructure, the integration plan must protect the relationships, incentives and culture that create value in the first place.

Assessing execution capacity requires more than confirming that a transaction can be completed. Leaders should consider whether the organization has sufficient management bandwidth, integration resources, technology readiness and change capacity to deliver the intended value while continuing to execute existing priorities. A transaction that looks attractive strategically may become less compelling if the organization lacks the capacity to absorb additional complexity.

Execution capacity should shape the pathway decision from the start.

5. Commit, Sequence or Keep Optionality

The final decision is not always whether to buy. It may be whether to commit, sequence or preserve optionality.

An insurer may begin with a commercial partnership, take a minority stake, secure governance rights, build internal capability in parallel or agree a path to future ownership if performance and strategic fit are proven. This makes optionality a form of disciplined design, not indecision.

Well-structured decisions generally provide boards with a clear rationale for action and an understanding of potential next steps. If the pathway performs as anticipated, the insurer may choose to deepen the commitment. If conditions change, it may adapt without sacrificing future options. Either way, the decision should be guided by strategic fit, capital discipline and execution reality.

From Growth Strategy to Ownership Strategy

The purpose of the Ownership Decision Framework is not to determine whether a deal is possible. It is to determine whether ownership may be the appropriate solution. By testing strategic need, deployable capital, execution capacity and optionality before acting, and by comparing realistic outcomes rather than idealized alternatives, insurers can evaluate ownership decisions in a more structured and informed manner before a transaction reaches the board.

Learn more about how Aon’s Strategy and Technology Group helps insurers evaluate growth opportunities and capital deployment decisions.

More options. More pathways. More informed decision making. That’s what could define the next phase of value creation.

This is the third article in a four‑part series on insurer growth pathways

It follows the first article and second article, which established why consolidation is changing and explained how to choose between growth pathways.

The remaining article builds progressively from this foundation:

  • Article 4: Why talent and culture now define M&A outcomes
    Explores how insurers translate strategic intent into value creation, showing why talent retention, cultural alignment and execution discipline are often the decisive factors in M&A success.
Continue the conversation

Get priority access to articles in this series and additional insights on how insurers are evolving their growth strategies.

Contact Us

Aon’s Thought Leaders
  • Colin Gleeson
    Managing Director, Strategy and Technology Group, United Kingdom
  • Piers Johansen
    Managing Director, Mergers and Acquisitions, Europe, Middle East and Africa
  • Kathleen Monaghan Ballo
    Head of Corporate Finance

General Disclaimer

This document is not intended to address any specific situation or to provide legal, regulatory, financial, or other advice. While care has been taken in the production of this document, Aon does not warrant, represent or guarantee the accuracy, adequacy, completeness or fitness for any purpose of the document or any part of it and can accept no liability for any loss incurred in any way by any person who may rely on it. Any recipient shall be responsible for the use to which it puts this document. This document has been compiled using information available to us up to its date of publication and is subject to any qualifications made in the document.

Terms of Use

The contents herein may not be reproduced, reused, reprinted or redistributed without the expressed written consent of Aon, unless otherwise authorized by Aon. To use information contained herein, please write to our team.

Important Information

This document is provided for general informational purposes only and does not constitute investment, legal, accounting, tax or other professional advice. It is not intended as, and should not be relied upon as, a recommendation, offer or solicitation to buy, sell or hold any security, to pursue any particular transaction or strategy, or to engage any specific service. Any references to specific companies or transactions are illustrative only. Market conditions, regulations and other factors may change, and actual outcomes may differ materially from any views expressed. Insurers should make decisions based on their own objectives, financial situation, risk tolerance and regulatory requirements, and in consultation with their own professional advisors.

More Like This

View All
  • Three Human Capital Imperatives for M&A Success

    Article 6 mins

    Three Human Capital Imperatives for M&A Success

    As M&A activity accelerates, benefits leaders have an opportunity to influence transaction outcomes long before integration begins. By treating workforce strategy as an essential part of deal strategy, organizations can plan to reduce risk, move faster and improve long-term value creation.

  • Global Insurance Market Overview

    Article 28 mins

    Q3 2026: Global Insurance Market Overview

    The global commercial insurance market remained favorable in Q3, although opportunities varied by risk and line of business. As insurers maintained underwriting discipline alongside strong competition, well-managed risks with robust data continued to achieve the most favorable outcomes.

Subscribe CTA Banner